Albireo Pharma (ALBO) 10-K 2015 FY Annual report

Exhibit 32.01

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Biodel Inc. (the "Company") for the year ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned Errol De Souza, President and Chief Executive Officer of the Company and Gary G. Gemignani, Chief Financial Officer of the Company, each hereby certifies that: (1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Errol De Souza               
Errol De Souza,
President and
Chief Executive Officer
Dated: December 22, 2015

/s/ Gary G. Gemignani          
Gary G. Gemignani
Chief Financial Officer
Dated: December 22, 2015